Il-17A contributes to maintenance of pulmonary homeostasis in a murine model of cigarette smoke-induced emphysema

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 2, 2015, Pages L188-L195

  Voss, Meike ^a   Wolf, Lisa ^a   Kamyschnikow, Andreas ^a   Wonnenberg, Bodo ^a   Honecker, Anja ^a   Herr, Christian ^a   Lepper, Philipp M ^a   Wegmann, Michael ^b   Menger, Michael D ^a   Bals, Robert ^a   Beisswenger, Christoph ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Cigarette smoke; Emphysema; IL 17A; Lung damage; Pulmonary function

Indexed keywords

CIGARETTE SMOKE; ELASTIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; CYTOKINE; IL17A PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMPHYSEMA; HOMEOSTASIS; LUNG COMPLIANCE; LUNG FUNCTION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOLOGY; TOTAL LUNG CAPACITY; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; FORCED EXPIRATORY VOLUME; GENETICS; KNOCKOUT MOUSE; LUNG ALVEOLUS; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG LAVAGE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FORCED EXPIRATORY VOLUME; HOMEOSTASIS; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING;

EID: 84937458998     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00388.2014     Document Type: Article

References (47)

1. Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem WG, Deslee G, Moore CH, Jacobs ME, Conradi SH, Gierada DS, Pierce RA, Betsuyaku T, Senior RM. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 183: 876-884, 2011.
2. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 343: 269-280, 2000.
3. Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, Gambelli F, Ortiz LA, Martorana PA, Lungarella G. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 164: 886-890, 2001.
4. Chang Y, Nadigel J, Boulais N, Bourbeau J, Maltais F, Eidelman DH, Hamid Q. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 12: 43, 2011.
5. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls JK, Zheng M. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 6: e20333, 2011.
6. Churg A, Zhou S, Wang X, Wang R, Wright JL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 40: 482-490, 2009.
7. Davey A, McAuley DF, O'Kane CM. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J 38: 959-970, 2011.
8. Di SA, Caramori G, Gnemmi I, Contoli M, Vicari C, Capelli A, Magno F, D'Anna SE, Zanini A, Brun P, Casolari P, Chung KF, Barnes PJ, Papi A, Adcock I, Balbi B. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 157: 316-324, 2009.
9. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, Anderson IK, Brightling CE. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138: 1140-1147, 2010.
10. Gaffen SL. Structure and signaling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567, 2009.
11. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005.
12. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004, 1997.
13. Herr C, Han G, Li D, Tschernig T, Dinh QT, Beisswenger C, Bals R. Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model. Exp Toxicol Pathol 67: 261-269, 2015.
14. John-Schuster G, Hager K, Conlon TM, Irmler M, Beckers J, Eickelberg O, Yildirim AO. Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD. Am J Physiol Lung Cell Mol Physiol 307: L692-L706, 2014.
15. Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173: 3482-3491, 2004.
16. Knust J, Ochs M, Gundersen HJ, Nyengaard JR. Stereological estimates of alveolar number and size and capillary length and surface area in mice lungs. Anat Rec (Hoboken) 292: 113-122, 2009.
17. Kuang PP, Berk JL, Rishikof DC, Foster JA, Humphries DE, Ricupero DA, Goldstein RH. NF-+B induced by IL-1+ inhibits elastin transcription and myofibroblast phenotype. Am J Physiol Cell Physiol 283: C58-C65, 2002.
18. Kuang PP, Goldstein RH. Regulation of elastin gene transcription by interleukin-1+-induced C/EBP-isoforms. Am J Physiol Cell Physiol 285: C1349-C1355, 2003.
19. Laan M, Lotvall J, Chung KF, Linden A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogenactivated protein (MAP) kinases. Br J Pharmacol 133: 200-206, 2001.
20. Li D, Beisswenger C, Herr C, Hellberg J, Han G, Zakharkina T, Voss M, Wiewrodt R, Bohle RM, Menger MD, Schmid RM, Stockel D, Lenhof HP, Bals R. Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/beta-catenin signaling in murine and human tumor cells. Oncogene 33: 1239-1248, 2014.
21. Loffek S, Schilling O, Franzke CW. Series "matrix metalloproteinases in lung health and disease": biological role of matrix metalloproteinases: a critical balance. Eur Respir J 38: 191-208, 2011.
22. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159, 2008.
23. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442, 2006.
24. Mauviel A, Chen YQ, Kahari VM, Ledo I, Wu M, Rudnicka L, Uitto J. Human recombinant interleukin-1 beta up-regulates elastin gene expression in dermal fibroblasts. Evidence for transcriptional regulation in vitro and in vivo. J Biol Chem 268: 6520-6524, 1993.
25. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387, 2002.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
27. Pfeifer P, Voss M, Wonnenberg B, Hellberg J, Seiler F, Lepper PM, Bischoff M, Langer F, Schafers HJ, Menger MD, Bals R, Beisswenger C. IL-17C is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol 2012.
28. Pinart M, Zhang M, Li F, Hussain F, Zhu J, Wiegman C, Ryffel B, Chung KF. IL-17A modulates oxidant stress-induced airway hyperresponsiveness but not emphysema. PLoS One 8: e58452, 2013.
29. Prause O, Bozinovski S, Anderson GP, Linden A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 59: 313-317, 2004.
30. Roos AB, Sanden C, Mori M, Bjermer L, Stampfli MR, Erjefalt JS. IL-17A is elevated in end-stage COPD and contributes to cigarette smoke-induced lymphoid neogenesis. Am J Respir Crit Care Med 191: 1232-1241, 2015.
31. Seiler F, Hellberg J, Lepper PM, Kamyschnikow A, Herr C, Bischoff M, Langer F, Schafers HJ, Lammert F, Menger MD, Bals R, Beisswenger C. FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells. J Immunol 190: 1603-1613. 2013.
32. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N. Inducible NOS inhibition reverses tobaccosmoke-induced emphysema and pulmonary hypertension in mice. Cell 147: 293-305, 2011.
33. Sethi S. Infection as a comorbidity of COPD. Eur Respir J 35: 1209-1215, 2010.
34. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359: 2355-2365, 2008.
35. Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, Corry DB, Kheradmand F. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 4: 117ra9, 2012.
36. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163: 2329-2335, 2003.
37. Shen F, Li N, Gade P, Kalvakolanu DV, Weibley T, Doble B, Woodgett JR, Wood TD, Gaffen SL. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2: ra8, 2009.
38. Shifren A, Durmowicz AG, Knutsen RH, Hirano E, Mecham RP. Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysema. Am J Physiol Lung Cell Mol Physiol 292: L778-L787, 2007.
39. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B, Feng ZH. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181: 6117-6124, 2008.
40. Sproul EP, Argraves WS. A cytokine axis regulates elastin formation and degradation. Matrix Biol 32: 86-94, 2013.
41. Tan HL, Rosenthal M. IL-17 in lung disease: friend or foe? Thorax 2013.
42. Vanoirbeek JA, Rinaldi M, De V, V, Haenen S, Bobic S, Gayan-Ramirez G, Hoet PH, Verbeken E, Decramer M, Nemery B, Janssens W. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 42: 96-104, 2010.
43. Veeramachaneni SB, Sethi S. Pathogenesis of bacterial exacerbations of COPD. COPD 3: 109-115, 2006.
44. Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, McBurney MW, Guarente L, Gu W, Ronty M, Kinnula VL, Rahman I. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest 122: 2032-2045, 2012.
45. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J Immunol 155: 5483-5486, 1995.
46. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527, 2001.
47. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909, 2009.